Ionis Pharmaceuticals | IONS - Gross Profit On Sales



Ionis Pharmaceuticals reported $448M in Gross Profit on Sales for its fiscal quarter ending in June of 2025.


Gross Profit On Sales Change Date
Adcock Ingram Holdings ZAR 1.54B 73.26M Dec/2024
Agios Pharmaceuticals USD 10.75M 3.11M Jun/2025
Alnylam Pharmaceuticals USD 630.74M 107.59M Jun/2025
Arrowhead Research 27.77M 514.94M Jun/2025
Astellas Pharma JPY 410.96B 28.53B Jun/2025
BioMarin Pharmaceutical USD 670.47M 76.89M Jun/2025
Celltrion KRW 442.87B 100.93B Mar/2025
Cspc Pharmaceutical CNY 4.71B 391.66M Mar/2025
Divis Laboratories Ltd 14.54B 1.5B Jun/2025
Exelixis USD 548.79M 12.52M Jun/2025
Halozyme Therapeutics USD 279.36M 62.9M Jun/2025
Ionis Pharmaceuticals USD 448M 317.85M Jun/2025
Kangmei Pharma CNY 223.73M 38.54M Mar/2025
Knight Therapeutics CAD 45.02M 2.32M Sep/2024
Laboratorios Farma EUR 105.28M 177.08M Jun/2025
Malin Corporation EUR 3.8M 2.6M Dec/2020
Medical Developments International AUD 14.72M 1.36M Dec/2024
Moderna USD 18M 1000K Jun/2025
Neurocrine Biosciences USD 676.2M 112.8M Jun/2025
Novartis USD 11.51B 1.12B Jun/2025
OPKO Health USD 19.06M 65.54M Jun/2025
Organigram Holdings CAD 26.15M 25.1M Jun/2025
Pfizer USD 10.88B 248M Jun/2025
Pharma Mar EUR 53.61M 18.15M Jun/2025
PTC Therapeutics USD 163.39M 999.84M Jun/2025
Qiagen NV USD 334.29M 25.6M Jun/2025
Regeneron Pharmaceuticals USD 3.15B 581M Jun/2025
Roche Holding CHF 11.69B 48M Dec/2024
Sarepta Therapeutics USD 457.87M 149.43M Jun/2025
Sartorius EUR 416.2M 14.8M Jun/2025
Sino Biopharmaceutical CNY 10.5B 2.53B Dec/2024
Tilray USD 61.22M 1.51M Nov/2024
Ultragenyx Pharmaceutical USD 143.49M 32.86M Jun/2025
Vertex Pharmaceuticals USD 2.56B 150M Jun/2025
Zz Pientze Pharmaceu 296.13M 1.1B Jun/2025